Catalyst Wire Dossier Catalyst Wire Dossier

Jakafi

ruxolitinib · Incyte
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for Jakafi, covering 2011-11-16 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms [Phase 1, Phase 2]

See pricing